Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study

Lancet

Volumn 358, Issue 9288, 2001, Pages 1119-1123

  Channick, Richard N ^a   Simonneau, Gérald ^e   Sitbon, Olivier ^e   Robbins, Ivan M ^d   Frost, Adaani ^c   Tapson, Victor F ^f   Badesch, David B ^b   Roux, Sébastien ^g   Rainisio, Maurizio ^h   Bodin, Frédéric ^g   Rubin, Lewis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HÔPITAL ANTOINE BÉCLÈRE   (France)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g ACTELION PHARMACEUTICALS LTD   (Switzerland)

^h Statistics for Research Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIN; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ADULT; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPNEA; EXERCISE; FEMALE; HUMAN; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; WALKING;

EID: 0035818316     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06250-X     Document Type: Article

References (31)

1. Primary pulmonary hypertension
2. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis
3. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
4. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension
5. Survival in patients with primary pulmonary hypertension: Results from a national prospective registry
6. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
7. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized, controlled trial
8. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
9. Orally active prostacyclin analogue in primary pulmonary hypertension
10. Endothelin-1: A mediator of pulmonary hypertension?
11. Relation of endothelin-1 to survival in patients with primary pulmonary hypertension
12. Endothelin and collagen vascular disease: A review with special reference to Raynaud's phenomenon and systemic sclerosis
13. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
14. Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: Possible involvement of proinflammatory cytokines
15. Endothelin-1-like immunoreactivity in postobstructive pulmonary vasculopathy
16. B receptors
17. Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist
18. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats
19. Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension
20. The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure
21. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: Comparison with cardiopulmonary exercise testing
22. Psychophysical bases of perceived exertion
23. Endothelin antagonism with bosentan: A review of potential applications
24. Update of REACH-1 and MERIT-HF clinical trials in heart failure
25. Long-term, open-label experience with an endothelin receptor antagonist, bosentan, in patients with severe chronic heart failure
26. B receptor-mediated contraction in human pulmonary resistance arteries
27. B receptors
28. Endothelin receptors in cultured adult rat cardiac fibroblasts
29. Effects of Ro 47-0203 on endothelin-1 and sarafotoxin S6c-induced contractions of human bronchus and guinea-pig trachea
30. Role of endothelin in the increased vascular tone of patients with essential hypertension